Abstract:Background: Medulloblastoma (MB) is the most common malignant brain tumor in children. Approximately one-third of MB patients remain incurable. Understanding the molecular mechanism of MB tumorigenesis is, therefore, critical for developing specific and effective treatment strategies. Our previous work demonstrated that astrocytes constitute the tumor microenvironment (TME) of MB and play an indispensable role in MB progression. However, the underlying mechanisms by which astrocytes are regulated and activated to promote MB remain elusive. Methods: By taking advantage of Math1-Cre/Ptch1(loxp/loxp) mice, which spontaneously develop MB, primary MB cells and astrocytes were isolated and then subjected to administration and coculture in vitro. Immunohistochemistry was utilized to determine the presence of C3a in MB sections. MB cell proliferation was evaluated by immunofluorescent staining. GFAP and cytokine expression levels in C3a-stimulated astrocytes were assessed by immunofluorescent staining, western blotting, q-PCR and ELISA. C3a receptor and TNF-alpha receptor expression was determined by PCR and immunofluorescent staining. p38 MAPK pathway activation was detected by western blotting. Transplanted MB mice were treated with a C3a receptor antagonist or TNF-alpha receptor antagonist to investigate their role in MB progression in vivo. Results: We found that complement C3a, a fragment released from intact complement C3 following complement activation, was enriched in both human and murine MB tumor tissue, and its receptor was highly expressed on tumor-associated astrocytes (TAAs). We demonstrated that C3a activated astrocytes and promoted MB cell proliferation via the p38 MAPK pathway. Moreover, we discovered that C3a upregulated the production of proinflammatory cytokines, such as IL-6 and TNF-alpha in astrocytes. Application of the conditioned medium of C3a-stimulated astrocytes promoted MB cell proliferation, which was abolished by preincubation with a TNF-alpha receptor antagonist, indicating a TNF-alpha-dependent event. Indeed, we further demonstrated that administration of a selective C3a receptor or TNF-alpha receptor antagonist to mice subcutaneously transplanted with MB suppressed tumor progression in vivo. Conclusions: C3a was released during MB development. C3a triggered astrocyte activation and TNF-alpha production via the p38 pathway, which promoted MB cell proliferation. Our findings revealed the novel role of C3a-mediated TNF-alpha production by astrocytes in MB progression. These findings imply that targeting C3a and TNF-alpha may represent a potential novel therapeutic approach for human MB.

Sustained Hedgehog Signaling in Medulloblastoma Tumoroids is Attributed to Stromal Astrocytes and Astrocyte-Derived Extracellular Matrix

Abstract 5061: Astrocytes Promote Medulloblastoma Tumorigenesis Via Sonic Hedgehog Secretion

Astrocytes Promote Medulloblastoma Progression Through Hedgehog Secretion.

Author Correction: Failure of Human Rhombic Lip Differentiation Underlies Medulloblastoma Formation

Tumor Cells Generate Astrocyte-Like Cells That Contribute to SHH-driven Medulloblastoma Relapse.

Figure S2 from Astrocytes Promote Medulloblastoma Progression through Hedgehog Secretion

Figure S1 from Astrocytes Promote Medulloblastoma Progression Through Hedgehog Secretion

Complement C3a Activates Astrocytes to Promote Medulloblastoma Progression Through TNF-α

MEDU-37. CHOLESTEROL BIOSYNTHESIS REPRESENTS A NOVEL THERAPEUTIC TARGET FOR THE SONIC HEDGEHOG TYPE OF MEDULLOBLASTOMA

Sonic hedgehog medulloblastoma cells in co-culture with cerebellar organoids converge towards in vivo malignant cell states

228 Interaction Between MELK and EZH2 Regulates Medulloblastoma Cancer Stem-like Cells Proliferation

270 Inducing Neural Maturation and Increasing Survival in SHH Medulloblastoma Using EZH2 Inhibition in a Mouse Model

Figure S5 from Astrocytes Promote Medulloblastoma Progression through Hedgehog Secretion

OS10.7.A TUMOR-ASSOCIATED ASTROCYTES PROMOTE TUMOR PROGRESSION OF SONIC HEDGEHOG MEDULLOBLASTOMA BY SECRETING LCN2

Single-cell Transcriptomic Sequencing Identifies Subcutaneous Patient-Derived Xenograft Recapitulated Medulloblastoma

Human Fetal Cerebellar Cell Atlas Informs Medulloblastoma Origin and Oncogenesis

Single‐Cell Chromatin Accessibility Analysis Reveals Subgroup‐Specific TF‐NTR Regulatory Circuits in Medulloblastoma

Cdc14B/Cyclin B1 signaling modulates the pathogenesis of sonic hedgehog subtype medulloblastoma

Tmic-04. Spatial Sequencing Of Medulloblastoma Reveals Biological Niches Correlated With High-Risk Features And Relapse

NeuroD1 Dictates Tumor Cell Differentiation in Medulloblastoma.

Developmental basis of SHH medulloblastoma heterogeneity